ACP
ARAV

Acuta Capital Partners’s Aravive, Inc. Common Stock ARAV Stock Holding History

Acuta Capital Partners’s Portfolio ARAV Stock Details ARAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-8,183
Closed -$857K – 80
2017
Q2 		$857K Hold
8,183
– – 0.24% 47
2017
Q1 		$1.05M Buy
+8,183
New +$863K 0.25% 52

Other funds holding ARAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Acuta Capital Partners's ARAV Position: Q3 2015 in Review

Acuta Capital Partners sold out of Aravive, Inc. Common Stock (ARAV) in Q3 2015, closing a stake of 8,333 shares — an estimated $761K sold.

Acuta Capital Partners first reported a position in ARAV in Q2 2015 and held it in 1 quarter. The position peaked at $761K in Q2 2015. 63 funds tracked by Wall St. Rank hold ARAV as of Q3 2015.

  • Acuta Capital Partners reported no remaining Aravive, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Acuta Capital Partners sold 8,333 Aravive, Inc. Common Stock shares in Q3 2015, an estimated $761K.
  • Acuta Capital Partners first reported a position in Aravive, Inc. Common Stock in Q2 2015 and held it in 1 quarter.
  • Acuta Capital Partners's Aravive, Inc. Common Stock position peaked at $761K in Q2 2015.
  • 63 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q3 2015.

Based on Acuta Capital Partners's 13F filing for Q3 2015, filed 16 Nov 2015.